Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis

NCT ID
NCT07800351
Registry status
Not yet recruiting
Study type
Not specified in the registry data
Phase
Phase 3
Sponsor
Tanta University

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Enrollment: 46 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages
Not specified in the registry data
Sex
Not specified in the registry data
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: 1. Adults aged 18-70 years, diagnosed with rheumatoid arthritis (RA) according to the 2010 ACR/EULAR classification criteria. 2. Receiving conventional synthetic disease-modifying antirheumatic drug (csDMARD) therapy for at least 3 months. 3. Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. Exclusion Criteria: 1. Chronic autoimmune disease other than rheumatoid arthritis. 2. RA patients receiving biological DMARDs (bDMARDs). 3. Patients on lipid-lowering drugs (e.g., statins, fibrates). 4. Patients with metabolic or endocrine disease (e.g., diabetes mellitus, dyslipidemia). 5. Severe renal or hepatic impairment. 6. Any history of malignancy. 7. Current pregnancy or breastfeeding. 8. Current acute or chronic infection. 9. Currently participating in or has participated in a study of an investigational agent or device within 30 days prior to screening. 10. Known hypersensitivity or allergy to nicorandil or any of its components.

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: Egypt

  • Gharbia Governorate, Egypt: 1

Sample of listed locations

  • Rheumatology, Rehabilitation and Physical Medicine department -Tanta university hospitals — Tanta, Gharbia Governorate, 31511, Egypt — Site recruitment status not specified in the registry data

Study details

Start date
September 1, 2026
Primary completion date
February 1, 2027
First posted
September 2, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07800351
Registry last updated
September 11, 2026
QualifiedStudies registry data refreshed
September 21, 2026

View NCT07800351 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Arthritis studies | Clinical trial FAQ